SCHEMBL24257935

SCHEMBL24257935

CCCCCc1ccc(Oc2ccc(S(=O)(=O)Nc3ncc(C(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)O)cn3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.40
PKM P14618 2/20 0.40
AKT1 P31749 2/20 0.39
IRS1 P35568 2/20 0.39
GAB1 Q13480 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 1/20 0.38
POLB P06746 1/20 0.38
PTGDR Q13258 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 1/20 0.37
RECQL P46063 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 2/20 0.37
PSEN1 P49768 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22079911 0.97 ALDH1A1 (0.38) SMN1; SMN2PKMAKT1IRS1GAB1
SCHEMBL24257940 0.96 AKT1 (0.42) SMN1; SMN2PKMAKT1IRS1GAB1
SCHEMBL24257905 0.95 NPC1 (0.42) SMN1; SMN2PKMAKT1IRS1GAB1
SCHEMBL24257854 0.94 SMN1; SMN2 (0.41) SMN1; SMN2PKMAKT1IRS1GAB1
SCHEMBL22080331 0.92 TDP1 (0.38) SMN1; SMN2PKMTDP1MEN1KMT2A
SCHEMBL24257981 0.92 HDAC3 (0.41) SMN1; SMN2PKMAKT1IRS1GAB1
SCHEMBL24257979 0.90 MEN1 (0.37) SMN1; SMN2PKMTDP1MEN1KMT2A
SCHEMBL24257845 0.90 SLC9A3 (0.38) SMN1; SMN2PKMTDP1NPC1PTGDR
SCHEMBL24257988 0.88 NPC1 (0.40) SMN1; SMN2PKMTDP1MEN1KMT2A
SCHEMBL22079946 0.88 NPC1 (0.40) SMN1; SMN2PKMTDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048968-A1 INSULIN CONJUGATES SANOFI (FR) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048968-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R SMN1; SMN2 1332/4885PKM 1743/4885AKT1 1118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.